Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FH459
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $92,746
Award facts
- Contract value 100% obligated
- $92,746.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $92,746.18 delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 18, 2026, under a firm fixed-price contract type with an ultimate completion date of January 20, 2026. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside, competitively awarded delivery order issued under Amerisourcebergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. (formerly known as Amerisourcebergen), serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement needs, particularly supporting military and veteran healthcare systems.
Under this delivery order, Amerisourcebergen Drug Corp will supply pharmaceutical products and medical supplies as part of DLA's broader medical supply chain operations supporting military treatment facilities and other federal healthcare programs. The contractor maintains extensive experience fulfilling federal pharmaceutical requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The DLA is currently planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with the intent to make multiple awards across separate regions, positioning this delivery order within a larger strategic framework to ensure comprehensive pharmaceutical support for Department of Defense healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DU26FH459?
SPE2DU26FH459 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 18, 2026.
How much is contract SPE2DU26FH459 worth?
The government has obligated $92,746 on SPE2DU26FH459.
Is contract SPE2DU26FH459 an order under another contract?
Yes. SPE2DU26FH459 is a delivery order under SPE2DU25D4116, an indefinite delivery contract.
Was contract SPE2DU26FH459 competed?
The extent of competition for SPE2DU26FH459 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award